The Effect of Acupressure on Patients Receiving Brachytherapy
"The Effect of Acupressure on Anxiety, Pain and Vital Signs in Gynecological Cancer Patients Receiving Brachytherapy: A Randomized Controlled Study"
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aimed to use acupressure to reduce anxiety in gynecologic cancer patients receiving brachytherapy. It was also aimed to investigate the effects of acupressure on anxiety, pain, and vital signs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedStudy Start
First participant enrolled
August 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2024
CompletedAugust 1, 2024
July 1, 2024
18 days
April 18, 2024
July 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The State-Trait Anxiety Inventory
The Turkish validity and reliability of the State Anxiety Scale developed by Spielberger and his team in 1970 were conducted by Öner and Le Compte (1983). This scale is used to evaluate the emotional state that an individual feels at a specific moment and under specific conditions. The scale consists of 20 items and is evaluated on a four-point Likert scale (1-not at all, 2-somewhat, 3-very much, 4-completely). The scale includes both direct statements (3, 4, 6, 7, 9, 12, 13, 14, 17, 18) and reversed statements (1, 2, 5, 8, 10, 11, 15, 16, 19, 20).In direct statements, a value of 4 indicates high anxiety, while in reverse statements, a value of 1 signifies high anxiety. The total score range is 20-80, and this scoring is interpreted as follows: "no anxiety" between 0-19, "mild anxiety" between 20-39, "moderate anxiety" between 40-59, "severe anxiety" between 60-79, and a score of 80 is considered a "panic value.
day 1
Visual Analog Scale
On a 10 cm ruler with "no pain" marked at one end and "worst pain imaginable" at the other, the patient indicates their perceived level of pain. The Visual Analog Scale (VAS) is reported to be more sensitive and reliable in assessing pain intensity compared to other single-dimensional scales in the measurement of pain severity according to the Numeric Rating Scale.
day 1
The Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale was developed by Zigmond and Snaith in 1983 (Zigmond AS \& Snaith RP, 1983). It is stated that the scale is a reliable tool for detecting depression and anxiety in outpatient settings and provides valid measurements of the severity of emotional disorders through depression and anxiety subscales. In the scale consisting of 14 items, odd-numbered items investigate the anxiety sub-dimension, even-numbered items investigate the depression sub-dimension. It has a four-point Liket type feature between 0 and 3 points. Scoring for odd-numbered items 1, 3, 5, 6, 8, 10, 11 and 13 is 3, 2, 1, 0. Even items 2, 4, 7, 9, 12 and 14 are scored as 0,1,2,3. The scale score range is between 0-42. The cut-off score for the anxiety subscale was reported as 10, and the cut-off score for the depression subscale was reported as 7. Individuals who score above these scores constitute the risk group.
day 1
Vital signs
Body temperature, Blood pressure, Pulse, Respiration; will be manually assessed by the researcher for 1 minute. Record will be made on the Personal Information Form.
day 1
Study Arms (2)
Study
EXPERIMENTALAcupressure
Control
NO INTERVENTIONOnly routine practices of the clinic will be carried out
Interventions
Acupressure application protocol will be started after patient information. This process is planned to take 30 minutes.Before the application, approximately 20 seconds of warming and rubbing without direct pressure on the acupressure points will be performed to reduce tissue sensitivity and prepare the points for acupressure. Subsequently, the researcher will apply pressure with the thumb on the predetermined acupressure points, considering the individual's pain threshold, with 10 seconds of pressure followed by two seconds of relaxation without lifting the finger, in consecutive presses following the rhythm of breathing. A digital clock (belonging to the researcher) will be used to determine the duration of the acupressure application.
Eligibility Criteria
You may qualify if:
- Being registered in Selçuk University Faculty of Medicine Hospital Radiation Oncology Polyclinic
- Brachytherapy (intracavital brachytherapy) treatment protocol will be applied due to gynecological cancer.
- to be
- Karnofsky Performance Scale being 80 and above (Performance scale for cancer patients)
- Being between the ages of 18 and 65
- Being conscious and cooperative
- Verbal and written approval to participate in the study after an explanation about the study is made.
You may not qualify if:
- Impaired skin integrity in the acupressure application area
- Refuses to participate in the study after making a statement about the study.
- Bone or spine metastasis
- Amputation of the extremities to be applied
- Not having any mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ülkü Saygili Düzova
Selçuklu, Konya, Turkey (Türkiye)
Related Publications (1)
Duzova US, Can G, Duzova M, Basaran H, Yavas C. The effect of acupressure on anxiety, depression, pain, and vital signs in gynecological cancer patients receiving brachytherapy: A randomized controlled study. Support Care Cancer. 2025 Jul 18;33(8):698. doi: 10.1007/s00520-025-09754-6.
PMID: 40679634DERIVED
Study Officials
- STUDY DIRECTOR
ülkü Saygili Düzova
Selçuk Üniversitesi Hemşirelik Fakültesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof
Study Record Dates
First Submitted
April 18, 2024
First Posted
August 1, 2024
Study Start
August 28, 2024
Primary Completion
September 15, 2024
Study Completion
October 10, 2024
Last Updated
August 1, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share